Hans Severens

888 total citations · 1 hit paper
13 papers, 628 citations indexed

About

Hans Severens is a scholar working on General Health Professions, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Hans Severens has authored 13 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in General Health Professions, 7 papers in Economics and Econometrics and 3 papers in Epidemiology. Recurrent topics in Hans Severens's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Healthcare cost, quality, practices (3 papers) and Chronic Disease Management Strategies (2 papers). Hans Severens is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Healthcare cost, quality, practices (3 papers) and Chronic Disease Management Strategies (2 papers). Hans Severens collaborates with scholars based in Netherlands, United Kingdom and Taiwan. Hans Severens's co-authors include Marc Koopmanschap, Werner Brouwer, Marieke Krol, Leona Hakkaart‐van Roijen, Clazien Bouwmans, Alex Burdorf, Willem Jan Meerding, Maiwenn Al, Steve Ryder and Jos Kleijnen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Psychosomatic Research and Health Technology Assessment.

In The Last Decade

Hans Severens

12 papers receiving 605 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The iMTA Productivity Cost Questionnaire

2015 315 citations Clazien Bouwmans, Marieke Krol et al. Value in Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Severens Netherlands	9	162	161	97	95	81	13	628
Sumati Rao United States	8	156 1.0×	205 1.3×	54 0.6×	90 0.9×	119 1.5×	8	921
Mona L. Martin United States	15	112 0.7×	99 0.6×	96 1.0×	248 2.6×	185 2.3×	43	1.1k
Ashutosh Gupta India	16	151 0.9×	149 0.9×	87 0.9×	246 2.6×	140 1.7×	48	850
Ghislaine van Mastrigt Netherlands	15	162 1.0×	281 1.7×	89 0.9×	192 2.0×	108 1.3×	46	966
Sarah Whitehead United Kingdom	4	175 1.1×	361 2.2×	60 0.6×	127 1.3×	90 1.1×	7	793
Josep Darbà Spain	16	101 0.6×	191 1.2×	140 1.4×	105 1.1×	131 1.6×	109	906
Frank Verheyen Germany	16	199 1.2×	149 0.9×	73 0.8×	140 1.5×	162 2.0×	53	1.2k
Rachel Halpern United States	15	52 0.3×	96 0.6×	92 0.9×	147 1.5×	46 0.6×	42	822
Maureen C. O’Keeffe Rosetti United States	10	88 0.5×	106 0.7×	90 0.9×	90 0.9×	293 3.6×	18	828
Laura L. Sessums United States	11	301 1.9×	155 1.0×	55 0.6×	148 1.6×	91 1.1×	19	893

Countries citing papers authored by Hans Severens

Since Specialization

Citations

This map shows the geographic impact of Hans Severens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Severens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Severens more than expected).

Fields of papers citing papers by Hans Severens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Severens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Severens. The network helps show where Hans Severens may publish in the future.

Co-authorship network of co-authors of Hans Severens

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Severens. A scholar is included among the top collaborators of Hans Severens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Severens. Hans Severens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bouwmans, Clazien, Marieke Krol, Hans Severens, et al.. (2015). The iMTA Productivity Cost Questionnaire. Value in Health. 18(6). 753–758. 315 indexed citations breakdown →

Ramiro, S., Hans Severens, Bruno Fautrel, et al.. (2015). OP0281 Rheumatologists Consider Patient Preferences and Costs when Choosing Treatments for Rheumatoid Arthritis (RA) Patients. A Cross-European Discrete Choice Experiment. Annals of the Rheumatic Diseases. 74. 178–179. 2 indexed citations

Whiting, Penny, Maiwenn Al, Steve Ryder, et al.. (2014). Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 18(18). 1–106. 80 indexed citations

Riemsma, Rob, Maiwenn Al, Isaac Corro Ramos, et al.. (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 17(61). 1–236. 39 indexed citations

Koopmanschap, Marc, Hans Severens, & M Franken. (2012). Internationale aspecten bij besluitvorming inzake geneesmiddelenvergoeding. Data Archiving and Networked Services (DANS). 97. 36–39. 1 indexed citations

Wensing, Michel, et al.. (2008). Determinants of health care use in chronic fatigue syndrome patients: A cross-sectional study. Journal of Psychosomatic Research. 65(1). 39–46. 10 indexed citations

Asselt, Antoinette D. I. van, Carmen D. Dirksen, Arnoud Arntz, et al.. (2007). Outpatient Psychotherapy for Borderline Personality Disorder: The Cost-Effectiveness of Schema-Focused Therapy Versus Transference-Focused Psychotherapy. SSRN Electronic Journal. 3 indexed citations

Steuten, Lotte, Stephen Palmer, Hubertus JM Vrijhoef, et al.. (2007). Cost-utility of a disease management program for patients with asthma. International Journal of Technology Assessment in Health Care. 23(2). 184–191. 27 indexed citations

Deckers, C. L. P., Irene A.W. Kotsopoulos, M.C.T.F.M. de Krom, et al.. (2007). A Cost-Effectiveness Decision Model for Antiepileptic Drug Treatment in Newly Diagnosed Epilepsy Patients. Value in Health. 10(3). 173–182. 11 indexed citations

10.

Hoomans, Ties, André J.H.A. Ament, Silvia Evers, & Hans Severens. (2006). Worthwhile Implementation of Evidence-Based Guidelines into Clinical Practice: How to Determine the Investment Potential for Guideline Implementation and the Value for Money of Implementation Strategies?. SSRN Electronic Journal. 3 indexed citations

11.

Steuten, Lotte, Hubertus JM Vrijhoef, Hans Severens, Frits van Merode, & Cor Spreeuwenberg. (2006). Are we measuring what matters in health technology assessment of disease management? Systematic literature review. International Journal of Technology Assessment in Health Care. 22(1). 47–57. 24 indexed citations

12.

Koopmanschap, Marc, et al.. (2005). Measuring Productivity Changes in Economic Evaluation. PharmacoEconomics. 23(1). 47–54. 99 indexed citations

13.

IJzerman, Maarten J., et al.. (2003). PRE-ASSESSMENT TO ASSESS THE MATCH BETWEEN COST-EFFECTIVENESS RESULTS AND DECISION MAKERS' INFORMATION NEEDS. International Journal of Technology Assessment in Health Care. 19(1). 17–27. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact